Sure is BNRICH...............I like this quote out of the article...........re Relenza and HOPEFUL PROSPECTS :-)
Quote
Several very hopeful prospects such as Relenza for flu and Lotronex for irritable bowel syndrome failed in the later stages of testing or did not prove to be commercially viable.
Garnier’s answer was to break up the company’s £3bn-a-year research organisation into several smaller units.
End Quote